Markella V Zanni1, Kathleen Fitch1, Corinne Rivard1, Laura Sanchez1, Pamela S Douglas2, Steven Grinspoon1, Laura Smeaton3, Judith S Currier4, Sara E Looby1,5. 1. a Program in Nutritional Metabolism , Mass General Hospital and Harvard Medical School , Boston , MA , USA. 2. b Cardiology Division and Duke Clinical Research Institute , Duke University School of Medicine, Duke University Hospital , Durham , NC , USA. 3. c Harvard T.H. Chan School of Public Health , Center for Biostatistics in AIDS Research , Boston , MA , USA. 4. d Division of Infectious Diseases , University of California, Los Angeles CARE Hospital and University of California, Los Angeles Medical School , Los Angeles , CA , USA. 5. e Yvonne L. Munn Center for Nursing Research , Mass General Hospital , Boston , MA , USA.
Abstract
BACKGROUND: Women's under-representation in HIV and cardiovascular disease (CVD) research suggests a need for novel strategies to ensure robust representation of women in HIV-associated CVD research. OBJECTIVE: To elicit perspectives on CVD research participation among a community-sample of women with or at risk for HIV, and to apply acquired insights toward the development of an evidence-based campaign empowering older women with HIV to participate in a large-scale CVD prevention trial. METHODS: In a community-based setting, we surveyed 40 women with or at risk for HIV about factors which might facilitate or impede engagement in CVD research. We applied insights derived from these surveys into the development of the Follow YOUR Heart campaign, educating women about HIV-associated CVD and empowering them to learn more about a multi-site HIV-associated CVD prevention trial: REPRIEVE. RESULTS: Endorsed best methods for learning about a CVD research study included peer-to-peer communication (54%), provider communication (46%) and video-based communication (39%). Top endorsed non-monetary reasons for participating in research related to gaining information (63%) and helping others (47%). Top endorsed reasons for not participating related to lack of knowledge about studies (29%) and lack of request to participate (29%). Based on survey results, the REPRIEVE Follow YOUR Heart campaign was developed. Interwoven campaign components (print materials, video, web presence) offer provider-based information/knowledge, peer-to-peer communication, and empowerment to learn more. Campaign components reflect women's self-identified motivations for research participation - education and altruism. CONCLUSIONS: Investigation of factors influencing women's participation in HIV-associated CVD research may be usefully applied to develop evidence-based strategies for enhancing women's enrollment in disease-specific large-scale trials. If proven efficacious, such strategies may enhance conduct of large-scale research studies across disciplines.
BACKGROUND:Women's under-representation in HIV and cardiovascular disease (CVD) research suggests a need for novel strategies to ensure robust representation of women in HIV-associated CVD research. OBJECTIVE: To elicit perspectives on CVD research participation among a community-sample of women with or at risk for HIV, and to apply acquired insights toward the development of an evidence-based campaign empowering older women with HIV to participate in a large-scale CVD prevention trial. METHODS: In a community-based setting, we surveyed 40 women with or at risk for HIV about factors which might facilitate or impede engagement in CVD research. We applied insights derived from these surveys into the development of the Follow YOUR Heart campaign, educating women about HIV-associated CVD and empowering them to learn more about a multi-site HIV-associated CVD prevention trial: REPRIEVE. RESULTS: Endorsed best methods for learning about a CVD research study included peer-to-peer communication (54%), provider communication (46%) and video-based communication (39%). Top endorsed non-monetary reasons for participating in research related to gaining information (63%) and helping others (47%). Top endorsed reasons for not participating related to lack of knowledge about studies (29%) and lack of request to participate (29%). Based on survey results, the REPRIEVE Follow YOUR Heart campaign was developed. Interwoven campaign components (print materials, video, web presence) offer provider-based information/knowledge, peer-to-peer communication, and empowerment to learn more. Campaign components reflect women's self-identified motivations for research participation - education and altruism. CONCLUSIONS: Investigation of factors influencing women's participation in HIV-associated CVD research may be usefully applied to develop evidence-based strategies for enhancing women's enrollment in disease-specific large-scale trials. If proven efficacious, such strategies may enhance conduct of large-scale research studies across disciplines.
Entities:
Keywords:
Clinical trials; Community-based research; HIV-associated cardiovascular disease; REPRIEVE; Research participation; Sex differences; Women
Authors: Quarraisha Abdool Karim; Judith D Auerbach; Simone E Buitendijk; Pedro Cahn; Mirjam J Curno; Catherine Hankins; Elly Katabira; Susan Kippax; Richard Marlink; Joan Marsh; Ana Marusic; Heidi M Nass; Julio Montaner; Elizabeth Pollitzer; Maria Teresa Ruiz-Cantero; Lorraine Sherr; Papa Salif Sow; Kathleen Squires; Mark A Wainberg; Shirin Heidari Journal: J Int AIDS Soc Date: 2012-03-08 Impact factor: 5.396
Authors: Kathleen V Fitch; Emma M Kileel; Sara E Looby; Markella V Zanni; Laura R Sanchez; Carl J Fichtenbaum; Edgar T Overton; Carlos Malvestutto; Judith A Aberg; Karin L Klingman; Beverly Alston-Smith; Judith Lavelle; Anne Rancourt; Sharlaa Badal-Faesen; Sandra Wagner Cardoso; Anchalee Avihingsanon; Sandesh Patil; Craig A Sponseller; Kathleen Melbourne; Heather J Ribaudo; Katharine Cooper-Arnold; Patrice Desvigne-Nickens; Udo Hoffmann; Pamela S Douglas; Steven K Grinspoon Journal: HIV Res Clin Pract Date: 2020-03-11
Authors: Steven K Grinspoon; Kathleen V Fitch; Edgar Turner Overton; Carl J Fichtenbaum; Markella V Zanni; Judith A Aberg; Carlos Malvestutto; Michael T Lu; Judith S Currier; Craig A Sponseller; Myron Waclawiw; Beverly Alston-Smith; Katharine Cooper-Arnold; Karin L Klingman; Patrice Desvigne-Nickens; Udo Hoffmann; Heather J Ribaudo; Pamela S Douglas Journal: Am Heart J Date: 2019-03-04 Impact factor: 4.749
Authors: Laura M Smeaton; Deborah Kacanek; Kateryna Mykhalchenko; Kristine Coughlin; Karin L Klingman; Susan L Koletar; Elizabeth Barr; Ann C Collier Journal: Clin Infect Dis Date: 2020-08-22 Impact factor: 9.079
Authors: Amelia M Stanton; Georgia R Goodman; Gregory K Robbins; Sara E Looby; Marcel Williams; Christina Psaros; Greer Raggio Journal: J Women Aging Date: 2022-02-24